Akorn, Inc $AKRX Catalysts are looming
Specialty pharmaceuticals, biotech, and even big cap pharma are exhibiting great relative price performance. One that we just purchased Monday, Akorn, Inc. (AKRX) on a sharp pullback based on…
“Making money in the market is really about investors with confidence taking it from those that lack it. Knowing that insiders are buying and not selling gives me that added confidence”, Harvey Sax, Top 10 long short equity fund manager according to BarclayHedge
